Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007340
Chunk: 112

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 112
---
 excess of the beneficial ownership limitation. The amounts and percentages in the table do not give effect to       
 the 4.99% beneficial ownership limitation, if applicable. Richard Abbe is the managing member of Iroquois Capital Investment Group LLC.       
 Mr. Abbe has voting control and investment discretion over securities held by Iroquois Capital Investment Group LLC. As such, Mr. Abbe        
 may be deemed to be the beneficial owner (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the        
 securities held by Iroquois Capital Investment Group LLC. The principal business address of Iroquois Capital Investment Group LLC is 2        
 Overhill Road, Suite 400, Scarsdale, NY 10583.                                                                                                |

| (11) | The selling shareholder holds (i) warrants issued by us in                                                                                    
 a prior transaction which entitle the selling shareholder to purchase an aggregate of 301,270,000 Ordinary Shares (in the form of Depositary  
 Shares), and (ii) Replacement Warrants issued by us which entitle the selling shareholder to purchase                                         
 an aggregate of 82,500,000 Ordinary Shares (in the form of Depositary Shares) and which we                                                    
 are registering hereby. The warrants are subject to a beneficial ownership limitation of 4.99%, which does not permit the selling shareholder 
 to exercise that portion of the warrants that would result in the selling shareholder and its affiliates owning, after exercise, a number     
 of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts and percentages in the table do not give effect to       
 the 4.99% beneficial ownership limitation, if applicable. Iroquois Capital Management L.L.C. is the investment manager of Iroquois Master     
 Fund, Ltd. Iroquois Capital Management, LLC has voting control and investment discretion over securities held by Iroquois Master Fund.        
 As Managing Members of Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page make voting and investment decisions on behalf        
 of Iroquois Capital Management, LLC in its capacity as investment manager to Iroquois Master Fund Ltd. As a result of the foregoing, Mr.      
 Abbe and Mrs. Page may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934,      
 as amended) of the securities held by Iroquois Capital Management and Iroquo